12
2023
-
01
Hubei Guangchen Pharmaceutical Allopurinol API Transfer A
Author:
On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.
On January 12, 2023, our company transferred allopurinol API to A, and the packaging specifications of this product are: 1kg/barrel, 5kg/barrel, 10kg/barrel, 25kg/barrel, or can be provided according to customer requirements.
Allopurinol and its metabolites can inhibit xanthine oxidase, prevent hypoxanthine and xanthine from converting to uric acid, thereby reducing the concentration of uric acid in the blood, reducing the deposition of uric acid salts in bones, joints, and kidneys, and can inhibit the production of uric acid synthesis.
Related News
Guangchen Pharmaceutical once again becomes a university practice base - A record of the Wuhan Institute of Technology (Hubei Guangchen Pharmaceutical Co., Ltd.) labor and practice base inauguration ceremony
2025-03-12
Hubei Guangchen Pharmaceutical held a grand commendation conference for the year 2024.
2025-02-05
Hubei Guangchen Pharmaceutical Co., Ltd. grandly held its 2024 annual work summary meeting
2025-02-03
Experts from the Hubei Provincial Office for the Prohibition of Chemical Weapons visited Guangchen Pharmaceutical for inspection and guidance on December 27, 2024.
2024-12-31

Carefully develop drugs with special indications using proprietary technology

Customer Service Hotline
Official website: www.hbgcyy.cn
Address: No. 19, Biopark 2nd Road, Biopark Industrial Park, High-tech Zone, Yichang City.
This website supports both IPV4 and IPV6 access.
Copyright © 2023 Guangchen Pharmaceutical ALL RIGHTS RESERVED.